{
    "symbol": "IMCC",
    "quarter": 4,
    "year": 2022,
    "date": "2023-03-29 10:20:25",
    "content": " Revenues for 2022 were $54.3 million compared to $34.1 million in 2021, an increase of 60%. Revenues for Q4 2022 were $14.5 million compared to $9.9 million in Q4 2021, an increase of 46%. Total dry flower sold in 2022 was approximately 6,794 kilos with an average selling price of $7.12 per gram compared to approximately 4,278 kilos in 2021 with an average selling price of $6.18 per gram. Total dried flower sold in Q4 2022 was approximately 2,330 kilos with an average selling price of $5.19 per gram compared to approximately 1,220 kilos in Q4 2021 with an average selling price of $6.87 per gram. Gross profit for 2022 was $9.2 million compared to $6.3 million in 2021, an increase of 46%. Gross profit for Q4 2022 was $2.6 million compared to $0.98 million in Q4 2021, an increase of 165%. General and administrative expenses in 2022 were $21.5 million compared to $17.2 million in 2021, an increase of 25%. General and administrative expenses in Q4 2022 were $9.8 million compared to $5.4 million in Q4 2021, an increase of 81%. The increase in the general and administrative expenses is attributable mainly to a full year consolidation of the previously acquired Israeli entities that were not fully consolidated in 2021, as well as the nonrecurring costs related to fair value adjustment of company's purchase option over pharmacy. Selling and marketing expenses in 2022 were $11.5 million compared to $6.7 million in 2021, an increase of 72%. Selling and marketing expenses in Q4 2022 were $3.1 million compared to $2.9 million in Q4 2021, an increase of 7%. Total assets as of December 31, 2022 were $60.7 million compared to $287.4 million in December 31, 2021, a decrease of 79%. Total liabilities as of December 31, 2022 were $36.9 million compared to $82.4 million in December 31, 2021, a decrease of approximately 55%."
}